Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection in cataract surgery for type 2 diabetes
NCT05413330Phase 3Completed
- Sponsor
- Damascus University
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone in diabetic macular edema (DME), diabetic retinopathy (DR), sponsored by Damascus University. Started Sep 2020; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT05413330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05413330.